Abstract
Purpose
Soft tissue sarcomas (STS) of the extremities in children are a heterogeneous group of tumors with a very different prognosis for which optimal treatment remains controversial.
Patients and methods
We retrospectively evaluated 97 patients younger than 15 years old affected by limb soft tissue sarcomas. All cases were histologically revised, and tumor grade was assessed according to the FNLCC system. Thirty-two were rhabdomyosarcoma (RMS) and 65 non-rhabdomyosarcoma (NRMSTS); among these, 40 (61.5%) were grade 3 according to FNLCC classification. Overall survival, local recurrence and distant metastasis were analyzed.
Results
Overall survival was 77.8% at 5 years and 69.7% at 10 years. Among grade 3 tumors, RMS had a worse prognosis over NRSTS. Similarly, tumors larger than 5 cm had a worse prognosis compared to smaller ones. Local recurrence-free survival was 90.7% at 5 years and 87.1% at 10 years with a better local control in grade 3 NRSTS over RMS and in tumors smaller than 2 cm.
Conclusion
Children affected by extremities RMS were confirmed to have the worst prognosis, in particular in case of metastasis at presentation. Differently from adult patients, hand and feet locations are frequent site for STS and 2 cm diameter should be taken as cut off for higher risk of LR. Similarly to adulthood STS, grading correlates with prognosis in NRSTS. The identification of prognostic variables should enable risk-adapted therapies to be planned.
Similar content being viewed by others
References
Grovas A, Fremgen A, Rauck A, Ruymann FB, Hutchinson CL, Winchester DP, Menck HR (1997) The National Cancer Data Base report on patterns of childhood cancers in the United States. Cancer 80(12):2321–2332
Siegel DA, King J, Tai E, Buchanan N, Ajani UA, Li J (2014) Cancer incidence rates and trends among children and adolescents in the United States, 2001–2009. Pediatrics 134(4):e945–e955. doi:10.1542/peds.2013-3926
Williams RF, Fernandez-Pineda I, Gosain A (2016) Pediatric sarcomas. Surg Clin North Am 96(5):1107–1125. doi:10.1016/j.suc.2016.05.012
Spunt SL, Skapek SX, Coffin CM (2008) Pediatric nonrhabdomyosarcoma soft tissue sarcomas. Oncologist 13(6):668–678. doi:10.1634/theoncologist.2007-0182
Kapoor G, Das K (2012) Soft tissue sarcomas in children. Indian J Pediatr 79(7):936–942. doi:10.1007/s12098-011-0560-4
Sangkhathat S (2015) Current management of pediatric soft tissue sarcomas. World J Clin Pediatr 4(4):94–105. doi:10.5409/wjcp.v4.i4.94
Dasgupta R, Rodeberg DA (2012) Update on rhabdomyosarcoma. Semin Pediatr Surg 21(1):68–78. doi:10.1053/j.sempedsurg.2011.10.007
Loeb DM, Thornton K, Shokek O (2008) Pediatric soft tissue sarcomas. Surg Clin North Am 88(3):615–627, vii. doi:10.1016/j.suc.2008.03.008
Ferrari A, Miceli R, Meazza C, Zaffignani E, Gronchi A, Piva L, Collini P, Podda M, Massimino M, Luksch R, Cefalo G, Terenziani M, Spreafico F, Polastri D, Fossati-Bellani F, Casanova M, Mariani L (2009) Soft tissue sarcomas of childhood and adolescence: the prognostic role of tumor size in relation to patient body size. J Clin Oncol 27(3):371–376. doi:10.1200/JCO.2007.15.4542
Pratt CB, Pappo AS, Gieser P, Jenkins JJ, Salzbergdagger A, Neff J, Rao B, Green D, Thomas P, Marcus R, Parham D, Maurer H (1999) Role of adjuvant chemotherapy in the treatment of surgically resected pediatric nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study. J Clin Oncol 17(4):1219. doi:10.1200/JCO.1999.17.4.1219
Bramwell VH (2001) Adjuvant chemotherapy for adult soft tissue sarcoma: is there a standard of care? J Clin Oncol 19(5):1235–1237
Yang JC, Chang AE, Baker AR, Sindelar WF, Danforth DN, Topalian SL, DeLaney T, Glatstein E, Steinberg SM, Merino MJ, Rosenberg SA (1998) Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 16(1):197–203
Reed DR, Hayashi M, Wagner L, Binitie O, Steppan DA, Brohl AS, Shinohara ET, Bridge JA, Loeb DM, Borinstein SC, Isakoff MS (2017) Treatment pathway of bone sarcoma in children, adolescents, and young adults. Cancer. doi:10.1002/cncr.30589
Blakely ML, Spurbeck WW, Pappo AS, Pratt CB, Rodriguez-Galindo C, Santana VM, Merchant TE, Prichard M, Rao BN (1999) The impact of margin of resection on outcome in pediatric nonrhabdomyosarcoma soft tissue sarcoma. J Pediatr Surg 34(5):672–675
Panda SP, Chinnaswamy G, Vora T, Prasad M, Bansal D, Kapoor G, Radhakrishnan V, Agarwala S, Laskar S, Arora B, Kaur T, Rath GK, Bakhshi S (2017) Diagnosis and management of rhabdomyosarcoma in children and adolescents: ICMR consensus document. Indian J Pediatr 84(5):393–402. doi:10.1007/s12098-017-2315-3
Terezakis SA, Wharam MD (2013) Radiotherapy for rhabdomyosarcoma: indications and outcome. Clin Oncol 25(1):27–35. doi:10.1016/j.clon.2012.07.009
Frustaci S, Gherlinzoni F, De Paoli A, Bonetti M, Azzarelli A, Comandone A, Olmi P, Buonadonna A, Pignatti G, Barbieri E, Apice G, Zmerly H, Serraino D, Picci P (2001) Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol 19(5):1238–1247. doi:10.1200/JCO.2001.19.5.1238
Walter AW, Shearer PD, Pappo AS, Greenwald CA, Rao BN, Bowman LC, Furman WL, Gajjar A, Jenkins JJ, Pratt CB (1998) A pilot study of vincristine, ifosfamide, and doxorubicin in the treatment of pediatric non-rhabdomyosarcoma soft tissue sarcomas. Med Pediatr Oncol 30(4):210–216
Million L, Donaldson SS (2012) Resectable pediatric nonrhabdomyosarcoma soft tissue sarcoma: which patients benefit from adjuvant radiation therapy and how much? ISRN Oncol 2012:341408. doi:10.5402/2012/341408
Enneking WF, Spanier SS, Goodman MA (1980) A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 153:106–120
Jo VY, Fletcher CD (2014) WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology 46(2):95–104. doi:10.1097/PAT.0000000000000050
Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, de Mascarel A, Goussot JF, David M, Bonichon F, Lagarde C (1984) Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 33(1):37–42
Rodeberg DA, Stoner JA, Garcia-Henriquez N, Randall RL, Spunt SL, Arndt CA, Kao S, Paidas CN, Million L, Hawkins DS (2011) Tumor volume and patient weight as predictors of outcome in children with intermediate risk rhabdomyosarcoma: a report from the Children’s Oncology Group. Cancer 117(11):2541–2550. doi:10.1002/cncr.25719
Malempati S, Rodeberg DA, Donaldson SS, Lyden ER, Anderson JR, Hawkins DS, Arndt CA (2011) Rhabdomyosarcoma in infants younger than 1 year: a report from the Children’s Oncology Group. Cancer 117(15):3493–3501. doi:10.1002/cncr.25887
Giuliano AE, Eilber FR (1985) The rationale for planned reoperation after unplanned total excision of soft-tissue sarcomas. J Clin Oncol 3(10):1344–1348. doi:10.1200/JCO.1985.3.10.1344
Ferrari A, Chi YY, De Salvo GL, Orbach D, Brennan B, Randall RL, McCarville MB, Black JO, Alaggio R, Hawkins DS, Bisogno G, Spunt SL (2017) Surgery alone is sufficient therapy for children and adolescents with low-risk synovial sarcoma: a joint analysis from the European paediatric soft tissue sarcoma Study Group and the Children’s Oncology Group. Eur J Cancer 78:1–6. doi:10.1016/j.ejca.2017.03.003
Bianchi G, Sambri A, Cammelli S, Galuppi A, Cortesi A, Righi A, Caldari E, Ferrari S, Donati D (2017) Impact of residual disease after “unplanned excision” of primary localized adult soft tissue sarcoma of the extremities: evaluation of 452 cases at a single Institution. Musculoskelet Surg. doi:10.1007/s12306-017-0475-y
Fawzy M, Sedky M, ElZomor H, El Sherbiny M, Salama E, Mahdy A (2016) Low-grade nonrhabdomyosarcoma soft tissue sarcoma: what is peculiar for childhood. J Pediatr Hematol Oncol 38(8):615–621. doi:10.1097/MPH.0000000000000657
Khoury JD, Coffin CM, Spunt SL, Anderson JR, Meyer WH, Parham DM (2010) Grading of nonrhabdomyosarcoma soft tissue sarcoma in children and adolescents: a comparison of parameters used for the Federation Nationale des Centers de Lutte Contre le Cancer and Pediatric Oncology Group Systems. Cancer 116(9):2266–2274. doi:10.1002/cncr.24929
Brennan MF, Antonescu CR, Moraco N, Singer S (2014) Lessons learned from the study of 10,000 patients with soft tissue sarcoma. Ann Surg 260(3):416–421. doi:10.1097/SLA.0000000000000869 (discussion 421–412)
Bianchi G, Sambri A, Righi A, Dei Tos AP, Picci P, Donati D (2017) Histology and grading are important prognostic factors in synovial sarcoma. Eur J Surg Oncol. doi:10.1016/j.ejso.2017.05.020
Spunt SL, Poquette CA, Hurt YS, Cain AM, Rao BN, Merchant TE, Jenkins JJ, Santana VM, Pratt CB, Pappo AS (1999) Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children’s Research Hospital. J Clin Oncol 17(12):3697–3705. doi:10.1200/JCO.1999.17.12.3697
Hayes-Jordan AA, Spunt SL, Poquette CA, Cain AM, Rao BN, Pappo AS, Shochat SJ (2000) Nonrhabdomyosarcoma soft tissue sarcomas in children: is age at diagnosis an important variable? J Pediatr Surg 35(6):948–953. doi:10.1053/jpsu.2000.6934 (discussion 953–944)
Smith MA, Altekruse SF, Adamson PC, Reaman GH, Seibel NL (2014) Declining childhood and adolescent cancer mortality. Cancer 120(16):2497–2506. doi:10.1002/cncr.28748
Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF (1996) Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 14(5):1679–1689. doi:10.1200/JCO.1996.14.5.1679
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All the authors declare that they have no conflict of interest. This study complies with the current laws of the country in which it was conducted.
Ethical standard
The study was approved by the local Ethic committee.
Informed consent
All patients signed an informed consent.
Rights and permissions
About this article
Cite this article
Sambri, A., Bianchi, G., Cucurnia, I. et al. Pediatric soft tissue sarcoma of the limbs: clinical outcome of 97 patients. Eur J Orthop Surg Traumatol 28, 1–7 (2018). https://doi.org/10.1007/s00590-017-2019-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00590-017-2019-4